Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology—A PROLONG-II Substudy

In patients with newly diagnosed heart failure with reduced ejection fraction (HFrEF), three months of optimal therapy are recommended before considering a primary preventive implantable cardioverter-defibrillator (ICD). It is unclear which patients benefit from a prolonged waiting period under prot...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Johanna Mueller-Leisse, Johanna Brunn, Christos Zormpas, Stephan Hohmann, Henrike Aenne Katrin Hillmann, Jörg Eiringhaus, Johann Bauersachs, Christian Veltmann, David Duncker
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2022-03-01
Edice:	Sensors
Témata:	HFrEF heart failure WCD (wearable cardioverter-defibrillator) ICD (implantable cardioverter-defibrillator) LVEF (left ventricular ejection fraction) SCD (sudden cardiac death)
On-line přístup:	https://www.mdpi.com/1424-8220/22/5/2037
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!